bupranolol has been researched along with Uterine Cervical Neoplasms in 1 studies
Bupranolol: An adrenergic-beta-2 antagonist that has been used for cardiac arrhythmia, angina pectoris, hypertension, glaucoma, and as an antithrombotic.
Uterine Cervical Neoplasms: Tumors or cancer of the UTERINE CERVIX.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our study indicates that ovarian cancer considerably alters contractile activity of the nonpregnant human uterus in response to ADRB antagonists." | 1.62 | Myometrial Responses to Beta-Adrenoceptor Antagonists in Gynecological Malignancies. ( Jóźwik, M; Kleszczewski, T; Modzelewska, B; Sulkowski, S, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Modzelewska, B | 1 |
| Jóźwik, M | 2 |
| Kleszczewski, T | 1 |
| Sulkowski, S | 1 |
1 other study available for bupranolol and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
Myometrial Responses to Beta-Adrenoceptor Antagonists in Gynecological Malignancies.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Bupranolol; Endometrial Neoplasms; Ethanolami | 2021 |